| Dr David Joseph Vastola, MD | |
|
222 Tongass Dr, Sitka, AK 99835-9416 | |
| (907) 966-8754 | |
| Not Available |
| Full Name | Dr David Joseph Vastola |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 222 Tongass Dr, Sitka, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710012323 | NPI | - | NPPES |
| MD2325 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 2325 (Alaska) | Primary |
| Entity Name | Southeast Alaska Regional Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376758037 PECOS PAC ID: 1456265362 Enrollment ID: O20031114000631 |
News Archive
A scientist at Leeds whose research is challenging conventional thinking on how the cholesterol-reducing drugs statins benefit cardiac patients, has secured funding to further investigate her findings.
A new study shows that coronary artery calcium (CAC) screening, an assessment tool that is not currently recommended for people considered at low risk, should play a more prominent role in helping determine a person's risk for heart attack and heart disease-related death, as well as the need for angioplasty or bypass surgery.
In a study published in The Lancet which analysed 1989 – 2003 data from the national Trauma Audit and Research Network database, the team compared the death-rates of patients with head injuries with those of other types of emergency patients and assessed the impact of neurosurgical care on these rates.
Researchers at the University of California, San Diego School of Medicine report that an oncogene dubbed ROR1, found on chronic lymphocytic leukemia (CLL) B cells but not normal adult tissues, acts as an accelerant when combined with another oncogene, resulting in a faster-developing, more aggressive form of CLL in mice.
Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. on ISIS-FXIRx, an antisense investigational drug in clinical development for the prevention of thrombosis. Under the agreement Bayer will further develop and commercialize ISIS-FXIRx in areas of high unmet medical need.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Joseph Vastola, MD 222 Tongass Dr, Sitka, AK 99835-9416 Ph: (907) 966-8754 | Dr David Joseph Vastola, MD 222 Tongass Dr, Sitka, AK 99835-9416 Ph: (907) 966-8754 |
News Archive
A scientist at Leeds whose research is challenging conventional thinking on how the cholesterol-reducing drugs statins benefit cardiac patients, has secured funding to further investigate her findings.
A new study shows that coronary artery calcium (CAC) screening, an assessment tool that is not currently recommended for people considered at low risk, should play a more prominent role in helping determine a person's risk for heart attack and heart disease-related death, as well as the need for angioplasty or bypass surgery.
In a study published in The Lancet which analysed 1989 – 2003 data from the national Trauma Audit and Research Network database, the team compared the death-rates of patients with head injuries with those of other types of emergency patients and assessed the impact of neurosurgical care on these rates.
Researchers at the University of California, San Diego School of Medicine report that an oncogene dubbed ROR1, found on chronic lymphocytic leukemia (CLL) B cells but not normal adult tissues, acts as an accelerant when combined with another oncogene, resulting in a faster-developing, more aggressive form of CLL in mice.
Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. on ISIS-FXIRx, an antisense investigational drug in clinical development for the prevention of thrombosis. Under the agreement Bayer will further develop and commercialize ISIS-FXIRx in areas of high unmet medical need.
› Verified 1 days ago
Jennifer Susan Mcnichol, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 222 Tongass Dr, Sitka, AK 99835 Phone: 907-966-2411 Fax: 907-966-8444 |